Blog
RSS FeedPosted by Michael Wonder on 30 Mar 2023
Clarity around PHARMAC’s priority lists
30 March 2023 - PHARMAC released its first Clarity Report, containing the latest information about medicines, vaccines, and related products ...
Posted by Michael Wonder on 13 Oct 2022
Clarity around PHARMAC’s priority lists (October 2022)
13 October 2022 - In March 2022, PHARMAC released its first Pūahoaho (clarity) Report, containing the latest information about its ...
Posted by Michael Wonder on 09 Mar 2022
Pūahoaho: clarity around PHARMACs priority lists
9 March 2022 - PHARMAC has released up to date information about its priority lists, including a list of ...
Posted by Michael Wonder on 16 Aug 2021
PHARMAC must explain funding decisions
16 August 2021 - “A report this morning that all PHARMAC staff, rather than clinical experts or those with patient ...
Posted by Michael Wonder on 28 Jul 2021
PHARMAC releases drug wish-list to be more 'transparent' but advocates say it gives false hope
28 July 2021 - PHARMAC has for the first time released a list of all the drugs it wants to ...
Posted by Michael Wonder on 28 Jul 2021
PHARMAC commits to being more transparent
28 July 2021 - For the first time, PHARMAC is sharing its priority lists for all funding applications for medicines ...
Posted by Michael Wonder on 01 Feb 2021
Patient advocate slams cancer agency report over 'wall of silence' on PHARMAC funding
2 February 2021 - The Cancer Control Agency has released its first report into cancer in New Zealand, but one patient ...
Posted by Michael Wonder on 12 Nov 2020
PHARMAC won’t release the data that changed its mind on diabetes
13 November 2020 - Diabetes Foundation Aotearoa will request the Ombudsman investigate the refusal by PHARMAC to release public submissions ...
Posted by Michael Wonder on 18 Aug 2019
Lack of transparency hampers cancer drug debate
19 August 2019 - The current debate raging over cancer drug funding is emotional, and the different agenda of lobby ...
Posted by Michael Wonder on 27 May 2019
Breast cancer treatments, rare disorders, venlafaxine
27 May 2019 - PHARMAC has published more information on its decisions on the funding of medicines for breast cancer, ...
Posted by Michael Wonder on 21 May 2019
Official Information Act response: adrenaline auto-injector cost utility analysis
20 May 2019 - PHARMAC responds to a request for any cost utility analyses performed by PHARMAC in relation to ...
Posted by Michael Wonder on 01 May 2019
PHARMAC sheds a little more light on procedures in savvy political move
1 May 2019 - Steve Maharey has just secured special status on David Clark's Christmas card list. ...
Posted by Michael Wonder on 29 Apr 2019
Proposal to decline inactive applications
29 April 2019 - To help make its decision-making process clearer, PHARMAC is seeking feedback on a proposal to make ...
Posted by Michael Wonder on 29 Apr 2019
PHARMAC proposes to give more clarity about funding decisions
29 April 2019 - An overhaul of PHARMAC’s decision-making process will give better insight into what medicines are - and ...
Posted by Michael Wonder on 14 Feb 2019
OIA responses: exploring ways to publish them
14 February 2019 - To support New Zealand's commitment to open government, PHARMAC is exploring ways to publish more of ...